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are unable to migrate to a site of injury. They are able to 
synthesize fibrous repair tissue, but not sufficiently to fill 
small defects (<3 mm in diameter) with a cartilage-like ma-
trix. Thus, many defects are not repaired and remain perma-
nently (2). Cartilage was used as one of the first models for 
research of in vitro engineered tissues and has shown the 
earliest application for cell-based therapy mainly due to its 
cellular homogeneity and avascularity (3). 
Chondrocytes within their natural environment actively 
synthesize and maintain their surrounding matrix. Mature 
chondrocytes have limited ability to proliferate and they are 
often mislabeled as dormant. In cell culture, human chon-
drocytes regain their ability to proliferate. Therefore, the 
basic premise behind Autologous Chondrocyte Implantation 
(ACI) is to overcome the inherent limitations of mature chon-
drocytes to effectively restore an injured articular surface. 
In monolayer culture, these cells respond by undergoing 
rapid proliferation. Histologically, these chondrocytes re-
versibly dedifferentiate, assuming a fibroblastic appearance 
and expressing type I collagen as opposed to type II collagen 
normally seen in articular cartilage. Once removed from the 
monolayer culture and placed in suspension or returned to 
the articular cartilage environment, cells undergo a rediffer-
entiation process into normal appearing chondrocytes and 
again produce type II collagen and proteoglycan aggregates 
(4).
In 1994 Brittberg et al. described the use of ACI in treat-
ing full-thickness AC defects from human knees (5). This 
was achieved in a two-stage procedure. Stage 1 involved 
arthroscopic biopsy of healthy AC and cultivation of the 
chondrocytes to produce between 5 and 10 million cells over 
a period of 4–6 weeks. Stage 2 involved debridement of the 
obJecTIves: the objective of the present study Was 
to determine if chondrocytes isolated from human 
cartilage of five elderly patients (mean age 63) With 
osteoarthritis (stage 3) maintain their proliferation 
and chondrogenic potential. isolation and cultivation 
of chondrocytes Was performed according to 
good laboratory practice (glp) standards.
MeThods: chondrocytes Were isolated from cartilage 
biopsy by enzymatic digestion. cultivation of cells Was 
performed in a controlled environment (cleanroom). 
phenotype characterization of chondrocytes 
Was achieved by floW cytometry analysis.
resulTs: three Weeks after cultivation, polygonal 
structures typical of chondrocytes Were observed, 
but spindle/fibroblast like morphology Was 
also detected in cultured cells. floW cytometric 
analysis shoWed that chondrocytes Were positive 
for cd44 (98.35% ± 0.50), cd90 (97.15% ± 0.13) after 
first passage (p1) and the cells Were negative 
for hematopoietic marker cd45 (0.21% ± 0.11).
conclusIons: human articular chondrocytes 
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and could be potentially used for autologous 
implantation. We have standardized the conditions 
for cultivation according to glp standards to 
minimize the risk of in vitro cell contamination.
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Introduction
Cartilage tissue is composed of chondrocytes embedded 
within a dense extracellular matrix (ECM). It has poor auton-
omous regeneration capacity, mainly due to its avascular na-
ture. Another factor contributing to poor regenerative capac-
ity of articular cartilage (AC) is the restricted number of ECM 
producing cells. The percentage of highly specialized chon-
drocytes in cartilage tissue is only 1–3% (1). Chondrocytes 
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pressurization, temperature, humidity and specialized fil-
tration were all tightly controlled. People and materials en-
tered and exited the cleanroom through airlocks (material 
pass box), gowning rooms and they wore special clothing 
designed to trap contaminants that are naturally generated 
by the body and skin. Cells were handled inside biological 
safety cabinets and cultivated in the gas incubators (figure 
1).
Isolation and cultivation of chondrocytes
Human cartilage tissue was harvested from the lateral fem-
oral condyle of 5 patients (mean age: 63 years) undergoing 
total knee replacement surgery due to osteoarthritis (stage 
3). Cartilage tissue was harvested in accordance with the 
ethical standards of L. Pasteur University Hospital commitee 
on human experimentation in Košice, Slovakia. Cartilage tis-
sue was placed into the transport medium containing sterile 
osteochondral lesions and coverage by a periosteal flap fol-
lowed by open implantation of these cells into the AC defect. 
Isolation and cultivation of chondrocytes is a widely 
spread technique. It is required in ACI as a treatment for os-
teochondritis dissecans (6), osteoarthritis (7) and articular 
cartilage injuries produced by trauma (8). In general, it can 
be used in any articular cartilage injury, where other sur-
gical procedures are not sufficient (4). In vitro chondrocyte 
manipulation is a crucial phase of autologous chondrocyte 
implantation. To minimize the risk of in vitro cell contami-
nation, the manipulation must be performed in a controlled 
environment such as a cleanroom according to good labo-
ratory practice (GLP). The GLP standards provide guidance 
on implementing GLP requirements critical for laboratory 
operations (9) (10).
In the current study, we have used basic methods for iso-
lation and cultivation of chondrocytes from human articular 
cartilage according to GLP standards. Phenotype character-
ization of chondrocytes was performed by flow cytometry 
analysis. 
Material and methods
Work in cleanroom according 
to GLP standards
Isolation and cultivation of chondrocytes were performed 
in the cleanroom in Associated Tissue Bank of the Faculty of 
Medicine of P. J. Šafárik University and L. Pasteur University 
Hospital in Košice, Slovakia. A cleanroom is a controlled 
environment where the concentration of airborne particles 
is controlled to specified limits (table 1). Contaminants gen-
erated by people, procedures, facilities and equipment were 
continually removed from the air. Air flow rates, direction, 
▲ Table 1. Cleanroom classification according to the number and size of particles permitted per volume of air. 
Class
Maximum particles/m3 FED STD 209E
equivalent≥0.1 µm ≥0.2 µm ≥0.3 µm ≥0.5 µm ≥1 µm ≥5 µm
ISO 1 10 2.37 1.02 0.35 0.083 0.0029
ISO 2 100 23.7 10.2 3.5 0.83 0.029
ISO 3 1,000 237 102 35 8.3 0.29 Class 1
ISO 4 10,000 2,370 1,020 352 83 2.9 Class 10
ISO 5 100,000 23,700 10,200 3,520 832 29 Class 100
ISO 6 1.0×106 237,000 102,000 35,200 8,320 293 Class 1,000
ISO 7 1.0×107 2.37×106 1,020,000 352,000 83,200 2,930 Class 10,000
ISO 8 1.0×108 2.37×107 1.02×107 3,520,000 832,000 29,300 Class 100,000
ISO 9 1.0×109 2.37×108 1.02×108 35,200,000 8,320,000 293,000 Room air
▲ Figure 1. Cleanroom facilities for cell cultivation according to 
GLP standards.
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(Invitrogen, GIBCO, USA). Aliquots of 100,000 cells were in-
cubated with mouse anti-human CD90-PE (Miltenyi Biotec 
Inc., USA), mouse anti-human CD44-PE (Miltenyi Biotec Inc., 
USA) and mouse anti-human CD45-FITC (Miltenyi Biotec 
Inc., USA) for 30 min in the dark. Flow cytometric analysis 
was performed with FACSCalibur flow cytometer (Becton 
Dickinson) and CellQuest software (Becton Dickinson). 
Chondrocytes were considered positive for a surface marker 
when the percentage of positive cells for that surface marker 
was ≥ to 95% and cells were considered negative for a surface 
marker when the percentage of positive cells for that surface 
marker was ≤ to 5%. The level of marker expression was cal-
culated as the ratio between geometric mean fluorescence 
intensity of sample cells and that of the negative control.
Results
Chondrocytes isolation and morphology
Cells isolated from human cartilage after enzymatic diges-
tion were seeded at 75 cm2 tissue culture flask (T75) at den-
sity 35,000 cells⁄cm2. The morphology of chondrocytes was 
observed under an inverted phase contrast light microscope 
(Leica DM IL). Non-adherent or low-adherent small round 
cells were also present in the primary culture after 4 days of 
cultivation. These cells were removed after the first medium 
change. Heterogeneous population of cells with different 
morphology was observed after 7 days of cultivation (figure 
2a). After 21 days of cultivation, chondrocytes showed a more 
polygonal structure, even though few cells had spindle/fi-
broblast like morphology (figure 2b). Chondrocytes reached 
confluence within 3 to 4 weeks. The average number of chon-
drocytes obtained after trypsinization (P1) was 2.23 x 106 ± 
0.5 per mL (table 2).
high-glucose Dulbecco’s modified Eagle medium (DMEM; 
Invitrogen, GIBCO, USA) supplemented with 1% antibiotic/
antimycotic solution (10,000 units/mL penicillin, 10,000 μg/
mL streptomycin, and 25 μg/mL amphotericin B; Invitrogen, 
GIBCO, USA). Cartilage tissue was minced with a scalpel to 
small pieces (1x1x1 mm) and digested with 0,1% bacterial 
collagenase type II (Invitrogen, GIBCO, USA) in Ham’s F-12 
(Biochrom AG) for 20 h at 37 ºC in 95% air and 5% CO2 hu-
midified atmosphere. Cell suspension was filtered by a 40 
μm nylon cell strainer (BD Falcon, Biosciences, Bedford, 
MA) to remove cell raft and matrix debris. The filtrate was 
then centrifuged at 150 x g for 7 min and the pellet was 
washed twice with DMEM (Invitrogen, GIBCO, USA). Isolated 
cells were suspended in cell culture medium containing 
Ham’s F-12 (Biochrom AG), 10% fetal bovine serum (FBS; 
Invitrogen, GIBCO, USA), 1% antibiotic/antimycotic solution 
(10,000 units/mL penicillin, 10,000 μg/mL streptomycin, 
and 25 μg/mL amphotericin B; Invitrogen, GIBCO, USA) and 
1% Insulin-Transferin-Selenium–A supplement (Invitrogen, 
GIBCO, USA). Chondrocytes were cultivated as a monolayer 
for expansion in 37 ºC humidified incubator with an atmos-
phere of 95% air and 5% CO2. The medium was changed 
twice weekly. Confluent layers of chondrocytes were dissoci-
ated with 0.05% Trypsin-EDTA solution (Invitrogen, GIBCO®, 
USA) and the number and viability of cells was assessed by 
TC10™ Automated Cell Counter (Bio-Rad Laboratories).
Characterization of chondrocytes
Phenotype characterization of chondrocytes after first 
passage (P1) was performed by flow cytometry. After de-
taching the cells from the tissue culture flasks, cells were 
washed twice with phosphate buffered saline solution 
(PBS; Invitrogen, GIBCO, USA) supplemented with 2% FBS 
▲ Figure 2. Representative phase-contrast photomicrographs (magnification: x100) of cultured human (A) 
chondrocytes, 7 days of cultivation at P0 (heterogenous cell population) (B) chondrocytes, 21 days of cultivation 
at P0 (spindle and polygonal shaped cells).
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chondrogenic potential. It is known that upon digestion of 
the ECM from a cartilage biopsy and subsequent adhesion 
to the culturing surface, chondrocytes re-enter the cell cy-
cle and proliferate. Three weeks after cultivation, polygonal 
structures typical of chondrocytes were observed, but spin-
dle/fibroblast like morphology was also detected in culture. 
Samples obtained from aged patients, even in regions of 
‘‘normal’’ appearing cartilage, are not metabolically nor-
mal and the chondrocyte phenotype is not stable in vitro, in 
particular in monolayer culture (12). Most data also suggest 
that the major phenotypic alterations are initially observed 
in surface areas of early-stage osteoarthritic cartilage, where 
chondrocytes express de novo abnormal, non-chondrocytic 
genes. In particular, they express the enzymes required for 
degrading the matrix that surrounds cells as well as many 
of the cytokines and growth factors relevant to turn on the 
catabolic processes within cartilage (13).
Immunophenotypic characterization of chondrocytes was 
performed by flow cytometry, which offers the possibility to 
assess and quantify a large number of epitopes on single 
cells within a short period of time. Immunophenotypic anal-
ysis of cells isolated from solid tissues through enzymatic 
digestions might be compromised due to the reduction or 
even total loss of surface molecules sensitive to enzymatic 
Phenotype characterization 
of chondrocytes
Flow cytometric analysis showed that chondrocytes were 
positive for CD44 (98.35% ± 0.50) and CD90 (97.15% ± 0.13) 
after first passage (P1) and cells were negative for hemato-
poietic marker CD45 (0.21% ± 0.11) (figure 3, table 2). Data are 
expressed as mean ± SD (n=5). 
Discussion
The objective of chondrocyte manipulation suitable for 
autologous implantation is to obtain viable and phenotyp-
ically stable cells able to enhance repair processes in the 
damaged area of human cartilage. Cells carry out the bal-
anced turnover of the extracellular matrix, which is neces-
sary for the integrity of the extracellular cartilage. In vitro ex-
pansion of chondrocytes is possible via monolayer culture, 
whereby cells alter their morphology and metabolism in a 
process known as dedifferentiation (11). The importance of 
monolayer expansion of cells from small biopsies relies on 
its clinical implementation in repair strategies such as autol-
ogous chondrocyte transplantation (5).
The aim of the present study was to determine if chondro-
cytes isolated from human cartilage of five elderly patients 
with osteoarthritis (stage 3) maintain their proliferation and 
▲ Figure 3. Flow cytometric analysis of chondrocytes (P1). Cells were positive for CD44, CD90 and negative for CD45.
▲ Table 2. Characterization of chondrocytes isolated from human cartilage of patients with osteoarthritis.
Sample 1 2 3 4 5 Average SD
Number of cells (×106) 2.53 1.62 2.35 1.81 2.82 2.23 0.50
Viability (%) 98.00 95.00 99.00 96.00 97.00 97.00 1.58
CD90 (%) 97.32 97.08 97.11 97.24 97.01 97.15 0.13
CD44 (%) 98.00 98.13 98.97 97.87 98.80 98.35 0.50
CD45 (%) 0.12 0.10 0.32 0.30 0.23 0.21 0.10
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treatment. Collagenase type II used in our study did not im-
pair the detection of the CD90, CD44 and CD45 markers. We 
have confirmed the expression of the hyaluronan receptor 
CD44 and C 90 (Thy-1) on chondrocytes (1P) as previously 
reported (14, 15, 16). The hyaluronan receptor CD44 belongs 
to the polymorphic family of CD44 glycoproteins, which are 
involved in several cellular functions including adhesion to 
hyaluronan and collagen, and which is present in normal 
chondrocytes (15). It was previously reported that CD90 
is also expressed in a minority of chondrocytes in normal 
articular cartilage (16). Up-regulation of markers on chon-
drocytes regarded as distinctive for mesenchymal stem cells 
(CD90 among others) during monolayer culture suggested 
that dedifferentiation leads to reversion to a primitive phe-
notype (17). Hematopoietic marker CD45 known as the leu-
kocyte common antigen was not expressed by chondrocytes. 
The CD45 marker should not be present in normal chondro-
cytes but can appear in dedifferentiated ones (15). 
It is important to enhance that cells used in this study 
were not applied in clinical practice and basic character-
ization of chondrocytes was the only aim of this study. A 
weakness of this study was the absence of a control group 
of healthy articular cartilage and from younger patients with 
osteoarthritis. This limitation was due to the lack of donors. 
Nonetheless, some researchers reported irreversible pheno-
typic changes between chondrocytes isolated from OA carti-
lage and chondrocytes from young healthy joints (18, 19, 20). 
Other reports indicate similar proliferation or differentiation 
potential of OA chondrocytes (21, 22).
Conclusion
Basic methods of in vitro isolation and cultivation of chon-
drocytes from OA cartilage were performed in this study. 
However, there were some limitations. More precise charac-
terization of surface and intracellular markers of chondro-
cytes as well as comparison with a control group of young 
healthy patients should have been practiced. In conclusion, 
human articular chondrocytes obtained from elderly pa-
tients with osteoarthritis (stage 3) maintained a chondrocyte 
phenotype and could be potentially used for autologous 
implantation. We have standardized the conditions for cul-
tivation to minimize the risk of in vitro cell contamination 
according to GLP standards since chondrocyte manipulation 
for autologous implantation requires standardized protocols 
to ensure that the cell product is therapeutically effective 
and safe.
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